INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,058,000 | -41.6% | 104,369 | -30.4% | 0.42% | -53.9% |
| Q1 2022 | $3,525,000 | +61.8% | 150,000 | +87.5% | 0.92% | +52.1% |
| Q4 2021 | $2,179,000 | -20.9% | 80,000 | -20.0% | 0.60% | -23.9% |
| Q3 2021 | $2,754,000 | +15.5% | 100,000 | +42.9% | 0.79% | +16.3% |
| Q1 2021 | $2,384,000 | +43.2% | 70,000 | +40.0% | 0.68% | +37.6% |
| Q4 2020 | $1,665,000 | +107.1% | 50,000 | +100.0% | 0.50% | +101.2% |
| Q3 2020 | $804,000 | – | 25,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |